Pharmacological management of personality disorders: from evidence to practice
Open accessAbstract
SUMMARY Clinical guidelines recommend avoiding the use of medications to manage personality disorder. In clinical practice, however, substantial amounts of medication are used. In this article, we summarise the recommendations of guidelines published in various countries in the past 15 years. We review the evidence from randomised controlled trials and recent reviews, discuss the discordance between guidance and clinical practice and give recommendations on what a clinician should consider if they choose to prescribe in cases of severe disturbances in mood or behaviour despite the lack of evidence.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is no strong empirical evidence supporting pharmacotherapy for PN, with medications primarily used to target comorbid symptoms such as mood instability, impulsivity, and aggression rather than core narcissistic traits.
“To date, there is no strong empirical evidence supporting pharmacotherapy for PN, with medications primarily used to target comorbid symptoms such as mood instability, impulsivity, and aggression rather than core narcissistic traits (77).”
From Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach (2025) · cites this paper as [77]
The paper says there is almost no evidence for pharmacotherapy in personality disorders other than those chiefly studied, and its ‘Identify target symptoms’ discussion lists mood instability, impulsivity and anger/hostility as possible medication targets (sections labelled References in our copy; no page numbers supplied). It does not specifically assess pathological narcissism (PN) or core narcissistic traits. Its discussion of prescribing practice also says clinicians often prescribed for personality-disorder symptoms rather than comorbid conditions, so the claim's description of these targets as primarily comorbid symptoms is not supported. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Understanding and misunderstanding randomized controlled trials
Deaton, A., & Cartwright, N. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.005 · Cited by 1,841 · see citing works
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302 · see citing works
Paton, C., Crawford, M., Bhatti, S. F., Patel, M. X., & Barnes, T. R. E. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09228 · Cited by 178 · see citing works
European guidelines for personality disorders: past, present and future
Simonsen, S., Bateman, A., Bohus, M., Dalewijk, H. J., Doering, S., Kaera, A., Moran, P., Renneberg, B., Ribaudi, J. S., Taubner, S., et al. (2019) · Borderline Personality Disorder and Emotion Dysregulation · doi:10.1186/s40479-019-0106-3 · Cited by 147 · see citing works
Brief Reports: Prospective Assessment of Treatment Use by Patients With Personality Disorders
Bender, D. S., Skodol, A. E., Pagano, M. E., Dyck, I. R., Grilo, C. M., Shea, M. T., Sanislow, C. A., Zanarini, M. C., Yen, S., McGlashan, T. H., et al. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.2.254 · Cited by 143 · see citing works
Gartlehner, G., Crotty, K., Kennedy, S. M., Edlund, M. J., Ali, R., Siddiqui, M., Fortman, R., Wines, R., Persad, E., & Viswanathan, M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00855-4 · Cited by 126 · see citing works
Pharmacological interventions for people with borderline personality disorder
Stoffers-Winterling, J. M., Storebø, O. J., Ribeiro, J. P., Kongerslev, M., Vӧllm, B., Mattivi, J. T., Faltinsen, E. G., Todorovac, A., Jørgensen, M. S., Edemann-Callesen, H., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012956.pub2 · Cited by 118 · see citing works
Antiepileptics for aggression and associated impulsivity
Huband, N., Ferriter, M., Nathan, R., & Jones, H. G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003499.pub3 · Cited by 114 · see citing works
Bridler, R., Häberle, A., Müller, S. T., Cattapan, K., Grohmann, R., Toto, S., Kasper, S., & Greil, W. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.017 · Cited by 106 · see citing works
Stoffers-Winterling, J. M., Storebø, O. J., & Lieb, K. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01164-1 · Cited by 79 · see citing works
Crisis interventions for people with borderline personality disorder
Borschmann, R., Henderson, C., Hogg, J., Phillips, R., & Moran, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009353.pub2 · Cited by 67 · see citing works
Zanarini, M. C., Frankenburg, F. R., Reich, D. B., Harned, A. L., & Fitzmaurice, G. M. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000232 · Cited by 64 · see citing works
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 61 · see citing works
Pharmacological interventions for antisocial personality disorder
Khalifa, N. R., Gibbon, S., Vӧllm, B., Cheung, N. H.-Y., & McCarthy, L. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007667.pub3 · Cited by 57 · see citing works
Antipsychotics for aggression in adults: A meta-analysis
van Schalkwyk, G. I., Beyer, C., Johnson, J. A., Deal, M., & Bloch, M. H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.019 · Cited by 45 · see citing works
An Introduction to the Fundamentals of Randomized Controlled Trials in Pharmacy Research
Houle, S. K. D. (2015) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v68i1.1422 · Cited by 42 · see citing works
Tyrer, P. J., & Mulder, R. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108951685 · Cited by 35 · see citing works
Lamotrigine for people with borderline personality disorder: a RCT
Crawford, M., Sanatinia, R., Barrett, B. M., Cunningham, G., Dale, O., Ganguli, P., Lawrence-Smith, G., Leeson, V. C., Lemonsky, F., Lykomitrou, G., et al. (2018) · Health Technology Assessment · doi:10.3310/hta22170 · Cited by 34 · see citing works
A Proposed Algorithm for the Pharmacotherapy of Impulsive Aggression.
Felthous, A. R., & Stanford, M. S. (2015) · PubMed · Cited by 27 · see citing works
Hoertel, N., López, S., Wang, S., González-Pinto, A. M., Limosin, F., & Blanco, C. (2015) · Personality Disorders Theory Research and Treatment · doi:10.1037/per0000091 · Cited by 24 · see citing works
A systematic review of the role of clozapine for severe borderline personality disorder
Han, J., Allison, S. C., Looi, J. C., Chan, S. K. W., & Bastiampillai, T. J. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06431-6 · Cited by 24 · see citing works
Is pharmacotherapy useful for treating personality disorders?
Stoffers-Winterling, J. M., Vӧllm, B., & Lieb, K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1873277 · Cited by 19 · see citing works
Critical Analysis of a Randomized Controlled Trial
Nimavat, B. D., Zirpe, K. G., & Gurav, S. K. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23638 · Cited by 14 · see citing works
Vӧllm, B., Chadwick, K., Abdelrazek, T., & Smith, J. F. (2012) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789949.2012.655764 · Cited by 12 · see citing works
Kadra-Scalzo, G., Garland, J., Miller, S., Chang, C., Fok, M. L.-Y., Hayes, R. D., Moran, P., Shetty, H., Young, A. H., & Stewart, R. J. (2021) · BJPsych Open · doi:10.1192/bjo.2021.34 · Cited by 5 · see citing works
Prescribing for emotionally unstable personality disorder: clinicians’ views
Javed, Q., Javed, S., Memon, B., & Okopi, O. (2022) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.759 · Cited by 5 · see citing works
A clinical approach to pharmacotherapy for personality disorders
Black, D. W. (2021) · Current Psychiatry · doi:10.12788/cp.0112 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Tyrer, P, Mulder, R (2022) Personality Disorder: From Evidence to Understanding. Cambridge University Press.CrossRefGoogle Scholar
Cited by
Sorted by citations
Albert, A. E., & Back, A. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1529427 · Cited by 6 · see citing works
Multimodal approaches to the treatment of personality disorder
Tyrer, P., King, J., & Mulder, R. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2515066 · Cited by 2 · see citing works
Rădoi, V., & Ruffalo, M. L. (2026) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2026.10210 · Cited by 1 · see citing works
Of polypharmacy and voids: pharmacotherapy in borderline personality disorder
Covarrubias-Castillo, S. A., & Barbosa‐Camacho, F. J. (2025) · BJPsych Advances · doi:10.1192/bja.2025.9
- Authors
- Völlm, B., & Cerci, D.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Cerci, Deniz
- Venue
- BJPsych Advances
- Publisher
- Royal College of Psychiatrists
- Published
- 2024-08-01
- Volume
- 31
- Issue
- 4
- Pages
- 214-222
- ISSN
- 2056-4678 (ISSN-L)
- 2056-4686
- OpenAlex
- W4401219906
- Cited by
- 4
- References
- 28
- Citations by year
- 2026: 1 · 2025: 3
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BJPsych Advances (publishedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Traits and Psychology
- Keywords
- personality disorders, pharmacological management, psychotropic drugs, guideline adherence, knowledge-practice gap, mood disturbance, behavioral problems, prescribing decisions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review